Approximately five percent of men and one percent of women aged over 65 years have an AAA, a weakening and dilatation of the main abdominal artery.
Most abdominal aortic aneurysms produce no symptoms and they are often incidentally discovered when abdominal ultrasounds or CT scans are ordered for other conditions.
Researchers at the Queensland Research Centre for Peripheral Vascular Disease, based at JCU in Townsville, in collaboration with researchers across Australia, are looking at ways to improve care for patients with AAA.
Professor Jonathan Golledge, from JCU’s School of Medicine and Dentistry, said the project was focusing on testing a new medication for AAA.
“Current management of AAA focuses on surgery, with no effective medications available,” he said.
“In this new study, researchers are seeking patients with small AAAs to take part in a clinical trial of a medication currently used to treat high blood pressure. Related studies designed to improve management of this condition are also being undertaken.”
Professor Golledge said if it proved effective, the new management approach could reduce the requirement for surgery by controlling artery weakening at an early stage in its development.
The researchers were looking for volunteers to take part in this research, he said.
“If you have an AAA and would like to take part we would like to hear from you.”
For further information please contact the research team on 07 4781 4727.
Contact details for interviews/photos: Professor Jonathan Golledge, School of Medicine and Dentistry, email@example.com, tel: 4781 4730 or 4781 4838.
JCU Media contact: Caroline Kaurila (07) 4781 4586 or 0437 028 175